EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology

Christine Tataru iD, Maya Livni, Carrie Marean-Reardon, Maria Clara Franco iD, Maude David iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289314 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Christine Tataru und 4 weiteren Autor:innen. Beteiligte Einrichtung: Oregon State University, College of Science, Microbiology, Corvallis, OR, United States of America. Hauptthemen laut MEDLINE: Cytokines, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Oregon State University College of Science SCiRisIII, regon State University Research Equipment Reserve Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 2 million people in North America suffer from inflammatory bowel disease (IBD), a chronic and idiopathic inflammatory condition. While previous research has primarily focused on studying immune cells as a cause and therapeutic target for IBD, recent findings suggest that non-immune cells may also play a crucial role in mediating cytokine and chemokine signaling, and therefore IBD symptoms. In this study, we developed an organ-on-a-chip co-culture model of Caco2 epithelial and HUVEC endothelial cells and induced inflammation using pro-inflammatory cytokines TNF- α and IFN- γ . We tested different concentration ranges and delivery orientations (apical vs. basal) to develop a consistently inducible inflammatory response model. We then measured pro-inflammatory cytokines and chemokines IL-6, IL-8, and CXCL-10, as well as epithelial barrier integrity. Our results indicate that this model 1. induces IBD-like cytokine secretion in non-immune cells and 2. decreases barrier integrity, making it a feasible and reliable model to test the direct actions of potential anti-inflammatory therapeutics on epithelial and endothelial cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesInflammatory Bowel DiseasesHumansCaco-2 CellsEndothelial CellsMicrophysiological SystemsIntestinal Mucosa

Substanzen

Cytokines

Autor:innen und Institutionen

  • Oregon State University, College of Science, Microbiology, Corvallis, OR, United States of America.
  • Oregon State University, College of Science, Biochemistry and Biophysics, Corvallis, OR, United States of America.
  • Florida International University, Herbert Wertheim College of Medicine, Center for Translational Science, Port St. Lucie, FL, United States of America.
  • Oregon State University, College of Pharmacy, Corvallis, OR, United States of America.

ORCID-Profile: Christine Tataru, Maria Clara Franco, Maude David

Förderung

  • NINDS NIH HHS
  • Oregon State University College of Science SCiRisIII
  • regon State University Research Equipment Reserve Fund
  • Larry W. Martin & Joyce B. O’Neill Endowed Fellowship
  • Oregon State University Microbiology Department

Zitieren

APA

Tataru, C., Livni, M., Marean-Reardon, C., Franco, M. C., & David, M. (2023). Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology. PLOS ONE. https://doi.org/10.1371/journal.pone.0289314

Vancouver

Tataru C, Livni M, Marean-Reardon C, Franco MC, David M. Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology. PLOS ONE. 2023. doi:10.1371/journal.pone.0289314

BibTeX
@article{Tataru2023,
  author = {Tataru, Christine and Livni, Maya and Marean-Reardon, Carrie and Franco, Maria Clara and David, Maude},
  title = {Cytokine induced inflammatory bowel disease model using organ-on-a-chip technology},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289314}
}
Kostenlos starten →